» Articles » PMID: 6339541

The Molecular Nature of Circulating Growth Hormone in Normal and Acromegalic Man: Evidence for a Principal and Minor Monomeric Forms

Overview
Specialty Endocrinology
Date 1983 May 1
PMID 6339541
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Human GH (hGH) extracted from pituitary glands consists of several molecular forms. Monomeric pituitary forms include the single chain 22,000-dalton polypeptide (22K; hGH-B), a 20,000-dalton variant with a 15-amino acid deletion (20K), 3 proteolytically cleaved 2-chain forms (hGH-C, -D, and -E), 2 deamidated forms, an acetylated form (fast hGH), and other, only partially characterized forms. It is not known which of these forms is secreted, nor what the precise nature of circulating hGH is. To answer these questions, we have extracted hGH from human plasma obtained by plasmapheresis from normal volunteers after L-dopa stimulation of hGH secretion and from acromegalic patients. We extracted and concentrated hGH by immunoadsorbent chromatography and examined its chemical nature by polyacrylamide gel electrophoresis under native and denaturing (sodium dodecyl sulfate and urea), nonreducing and reducing (dithiothreitol) conditions as well as by isoelectric focusing. In all cases, the predominant form of hGH present in plasma was 22K, which accounted for approximately 85% of all immunoreactive hGH. In addition, we found evidence for the presence of 20K as a minor form (approximately 7% of all hGH) and of one or more acidic forms (N-acetylated, deamidated, or cleaved hGH; 5-10% of all hGH). Exact identification of the acidic form(s) was not possible. However, the highly bioactive cleaved forms hGH-D and -E were judged to be undetectable (less than 5% of all hGH). We conclude that 1) several monomeric molecular forms of hGH circulate in normal and acromegalic man; 2) the pattern of circulating hGH forms reflects in part their relative prevalence in the pituitary gland; 3) proteolytically cleaved 2-chain hGH forms with enhanced bioactivity are not detectable in blood; and 4) monomeric hGH circulating in acromegaly is qualitatively indistinguishable from normal hGH.

Citing Articles

Growth hormone proteoformics atlas created to promote predictive, preventive, and personalized approach in overall management of pituitary neuroendocrine tumors.

Yang L, Li C, Song T, Zhan X EPMA J. 2023; 14(3):443-456.

PMID: 37605654 PMC: 10439873. DOI: 10.1007/s13167-023-00329-1.


Growth Hormone and Insulin-like Growth Factor-I Molecular Weight Isoform Responses to Resistance Exercise Are Sex-Dependent.

Pierce J, Martin B, Rarick K, Alemany J, Staab J, Kraemer W Front Endocrinol (Lausanne). 2020; 11:571.

PMID: 32973684 PMC: 7472848. DOI: 10.3389/fendo.2020.00571.


Molecular heterogeneity of human GH: from basic research to clinical implications.

Boguszewski C J Endocrinol Invest. 2003; 26(3):274-88.

PMID: 12809181 DOI: 10.1007/BF03345170.


Influence of the high-affinity growth hormone (GH)-binding protein on plasma profiles of free and bound GH and on the apparent half-life of GH. Modeling analysis and clinical applications.

Veldhuis J, Johnson M, Faunt L, Mercado M, Baumann G J Clin Invest. 1993; 91(2):629-41.

PMID: 8432866 PMC: 287997. DOI: 10.1172/JCI116243.


Stimulation of 2-deoxyglucose uptake in rat adipocytes by a human growth hormone fragment (hGH 4-15).

Ng F, Harcourt J Diabetologia. 1986; 29(12):882-7.

PMID: 3569692 DOI: 10.1007/BF00870144.